1. Home
  2. PLAG vs THAR Comparison

PLAG vs THAR Comparison

Compare PLAG & THAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLAG
  • THAR
  • Stock Information
  • Founded
  • PLAG 1986
  • THAR 2017
  • Country
  • PLAG United States
  • THAR United States
  • Employees
  • PLAG N/A
  • THAR N/A
  • Industry
  • PLAG Packaged Foods
  • THAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • PLAG Consumer Staples
  • THAR Health Care
  • Exchange
  • PLAG Nasdaq
  • THAR Nasdaq
  • Market Cap
  • PLAG 6.6M
  • THAR 5.5M
  • IPO Year
  • PLAG N/A
  • THAR 2022
  • Fundamental
  • Price
  • PLAG $0.87
  • THAR $1.82
  • Analyst Decision
  • PLAG
  • THAR Strong Buy
  • Analyst Count
  • PLAG 0
  • THAR 1
  • Target Price
  • PLAG N/A
  • THAR $17.00
  • AVG Volume (30 Days)
  • PLAG 838.0K
  • THAR 45.3K
  • Earning Date
  • PLAG 08-13-2025
  • THAR 08-08-2025
  • Dividend Yield
  • PLAG N/A
  • THAR N/A
  • EPS Growth
  • PLAG N/A
  • THAR N/A
  • EPS
  • PLAG N/A
  • THAR N/A
  • Revenue
  • PLAG $6,066,143.00
  • THAR N/A
  • Revenue This Year
  • PLAG N/A
  • THAR N/A
  • Revenue Next Year
  • PLAG N/A
  • THAR N/A
  • P/E Ratio
  • PLAG N/A
  • THAR N/A
  • Revenue Growth
  • PLAG N/A
  • THAR N/A
  • 52 Week Low
  • PLAG $0.47
  • THAR $0.95
  • 52 Week High
  • PLAG $5.52
  • THAR $6.39
  • Technical
  • Relative Strength Index (RSI)
  • PLAG 34.50
  • THAR 62.50
  • Support Level
  • PLAG $0.75
  • THAR $1.30
  • Resistance Level
  • PLAG $0.94
  • THAR $1.46
  • Average True Range (ATR)
  • PLAG 0.34
  • THAR 0.15
  • MACD
  • PLAG -0.13
  • THAR 0.05
  • Stochastic Oscillator
  • PLAG 13.52
  • THAR 79.41

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

About THAR Tharimmune Inc.

Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.

Share on Social Networks: